Quick Answer
Xtant Medical Holdings, Inc. reported Research And Development Expense of $2.10 million for the year ending 2025.
- Xtant Medical Holdings, Inc. showed a decrease of -11.9% in Research And Development Expense from 2024 to 2025.
- This data is from Xtant Medical Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $285.1 thousand | Q2 2013: $169.8 thousand | Q3 2013: $37.7 thousand | Q1 2014: $254.6 thousand | Q2 2014: $322.3 thousand | Q3 2014: $378.3 thousand | Q1 2015: $433.6 thousand | Q2 2015: $291.2 thousand | Q3 2015: $794.5 thousand | Q1 2016: $899.6 thousand | Q2 2016: $783.9 thousand | Q3 2016: $928.9 thousand | Q1 2017: $699.0 thousand | Q2 2017: $640.0 thousand | Q3 2017: $504.0 thousand | Q1 2018: $414.0 thousand | Q2 2018: $418.0 thousand | Q3 2018: $347.0 thousand | Q1 2019: $262.0 thousand | Q2 2019: $210.0 thousand | Q3 2019: $203.0 thousand | Q1 2020: $245.0 thousand | Q2 2020: $111.0 thousand | Q3 2020: $176.0 thousand | Q1 2021: $214.0 thousand | Q2 2021: $243.0 thousand | Q3 2021: $262.0 thousand | Q1 2022: $213.0 thousand | Q2 2022: $241.0 thousand | Q3 2022: $229.0 thousand | Q1 2023: $174.0 thousand | Q2 2023: $180.0 thousand | Q3 2023: $490.0 thousand | Q1 2024: $527.0 thousand | Q2 2024: $636.0 thousand | Q3 2024: $701.0 thousand | Q1 2025: $443.0 thousand | Q2 2025: $566.0 thousand | Q3 2025: $634.0 thousand.
- Over the full 13 years of available data (2013 to 2025), Xtant Medical Holdings, Inc.'s Research And Development Expense has grown by 267.3%.
- Historical annual values: Fiscal year 2025: $2.10 million | Fiscal year 2024: $2.39 million | Fiscal year 2023: $1.34 million | Fiscal year 2022: $915.0 thousand | Fiscal year 2021: $870.0 thousand | Fiscal year 2020: $657.0 thousand | Fiscal year 2019: $932.0 thousand | Fiscal year 2018: $1.70 million | Fiscal year 2017: $2.44 million | Fiscal year 2016: $3.41 million | Fiscal year 2015: $2.55 million | Fiscal year 2014: $1.44 million | Fiscal year 2013: $572.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: